Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

China Medical System

China Medical System
PUBLIC STATUS
1K-5K EMPLOYEES
00867 STOCK SYMBOL
8 INVESTMENTS
$1.46 SHARE PRICE (As of Friday Closing)
Description

China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies via Agency Network in China.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Devices and Supplies
Stock Exchange
HKG
Primary Office
  • No.11 Langshan Road
  • 6th Floor & 8th Floor, Building A Tongfang Information Harbour, Hi-tech Industrial Park North, Nansh
  • Shenzhen, 518057
  • China

+86 0755 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore China Medical System’s full profile, request a free trial.

China Medical System Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.78 - $1.67 $3.63B $1.46 $0.12 6.44M 2.48B

China Medical System Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 2,373,707 2,413,214 6,176,361 4,156,217
Revenue 841,687 821,348 791,488 735,766
EBITDA 335,977 340,300 306,224 255,046
Net Income 302,249 279,638 247,828 206,571
Total Assets 1,641,309 1,527,323 1,554,499 1,410,120
Total Debt 209,564 212,995 322,430 232,207
Public Fundamental Data provided by Morningstar, Inc. disclaimer

China Medical System Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000 06-Nov-2019 00000 00000 00 000.00 Biotechnology
00000000 000000 02-Apr-2019 0000 000.00 Biotechnology 000 0000
00000000 20-Nov-2018 00000 00000 00 000.00 Drug Discovery
000000 10-Oct-2018 000000000 000.00 Drug Discovery
Blueberry Therapeutics 14-Aug-2018 Later Stage VC 0000 Drug Discovery 000 0000
To view this company’s complete investment and acquisition history, request access »

China Medical System Executive Team (3)

Name Title Board
Seat
Contact
Info
Lam Kong President, Chairman & Chief Executive Officer
Chen Yanling Chief Financial Officer, Vice-President & Executive Director
Chen Hongbing Chief Operating Officer, Vice President & Executive Director

China Medical System Board Members (1)

Name Representing Role Since Contact
Info
000 0000 China Medical System President, Chairman & Chief Executive Officer 000 0000